Bosh sahifaAKBLF • OTCMKTS
add
ALK-Abello A/S
Yopilish kursi
27,65 $
Yillik diapazon
19,90 $ - 27,65 $
Bozor kapitalizatsiyasi
37,01 mlrd DKK
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
CPH
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (DKK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,52 mlrd | 12,66% |
Joriy xarajat | 547,00 mln | -4,54% |
Sof foyda | 354,00 mln | 52,59% |
Sof foyda marjasi | 23,26 | 35,47% |
Har bir ulushga tushum | 1,60 | 45,45% |
EBITDA | 540,00 mln | 41,36% |
Amaldagi soliq stavkasi | 25,16% | — |
Balans
Jami aktivlari
Jami passivlari
| (DKK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 517,00 mln | 77,66% |
Jami aktivlari | 8,19 mlrd | 20,70% |
Jami passivlari | 2,51 mlrd | 19,96% |
Umumiy kapital | 5,68 mlrd | — |
Tarqatilgan aksiyalar | 221,19 mln | — |
Narxi/balansdagi bahosi | 1,08 | — |
Aktivlardan daromad | 14,27% | — |
Kapitaldan daromad | 17,99% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (DKK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 354,00 mln | 52,59% |
Operatsiyalardan naqd pul | 389,00 mln | 37,46% |
Sarmoyadan naqd pul | -59,00 mln | 65,70% |
Moliyadan naqd pul | -399,00 mln | -34,80% |
Naqd pulning sof oʻzgarishi | -72,00 mln | 60,66% |
Boʻsh pul | 256,12 mln | 39,10% |
Haqida
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
Tashkil etilgan
1923
Sayt
Xodimlar soni
2 736
